Androgen Receptor (AR-V7 Specific) (E3O8L) Rabbit mAb 19672S from Cell Signaling Technology

Product Specs
ItemAndrogen Receptor (AR-V7 Specific) (E3O8L) Rabbit mAb
CompanyCell Signaling Technology
Price Pricing Info Supplier Page View Company Product Page
Catalog Number19672S
Quantity100 µl
ApplicationsW, W-S, IP, ChIP
ReactivityH
TargetAR-V7
IsotypeIgG
HostRabbit
NCBI Full Gene Nameandrogen receptor
NCBI Gene AliasesAIS, AR8, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM
ClonalityMonoclonal
Research AreaNuclear Receptor Signaling
Molecular Weight80

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Saracatinib synergizes with enzalutamide to downregulate AR activity in CRPCFrontiers in OncologyJune 30, 2023Ralph E. White, Maxwell Bannister, Abderrahman Day, Hannah E. Bergom, Victor M. Tan, Justin Hwang, Hai Dang Nguyen, Justin M. Draketotal PARP (rabbit CST: #9532). At 1:500, ARpS81 (rabbit Sigma-Aldrich: #07-1375), AR-V7 (rabbit CST: #19672). Blots are results in triplicate. 4.7 RNA sequencing and analysis Total RNA was isolated from 22Rv1

(2) Downregulation of AC092894.1 promotes oxaliplatin resistance in colorectal cancer via the USP3/AR/RASGRP3 axisBMC medicineApril 3, 2023Zheng Z, Wu M, Li H, Xu W, Yang M, Pan K, Ni Y, Jiang T, Zheng H, Jin X, et al.(12,490–1-AP). Cell Signaling Tech. Co. sold us immune responses against C-PARP (Lot No. 5625) and AR (Lot No. 19672). Lentiviral infection As per our previous study [15], 6-well plates were seeded with 293 T cells

(3) Hyaluronic acid-FGF2-derived peptide bioconjugates for suppression of FGFR2 and AR simultaneously as an acne antagonistJournal of NanobiotechnologyFebruary 17, 2023Zijian Su, Yibo Zhang, Jieqiong Cao, Yuanmeng Sun, Yuling Cai, Bihui Zhang, Liu He, Zilei Zhang, Junye Xie, Qilin Meng, et al.States of America), the membrane was then incubated with primary antibodies (Cell Signalling Technology #19672; #3471; #4691; #4060; #4370; #4695; #5174; #3700, US; Abcam #ab209899, UK) overnight at4 °C. The incubated

(4) A novel inhibitor of ARfl and ARv7 induces protein degradation to overcome enzalutamide resistance in advanced prostate cancerActa pharmaceutica Sinica. BNovember 1, 2022Li Y, Chu Y, Shi G, Wang X, Ye W, Shan C, Wang D, Zhang D, He W, Jiang J, et al.previously described27, with primary antibodies including ARfl (Abcam, Cat# ab74272), ARv7 (CST, Cat# 19672S), ARvs (Abcam, Cat# ab108341), PSA (CST, Cat# 5877S), Bax (Wanlei, Cat# WL01637A), Bcl-2 (Proteintech,

(5) AR-regulated ZIC5 contributes to the aggressiveness of prostate cancerCell death discoverySeptember 20, 2022Tan YF, Zhang Y, Ge SY, Zhong F, Sun CY, Xia GW.anti-TCF4 (22337-1-AP, Proteintech), anti-Histone H3 (ab1791, Abcam), anti-Tubulin (2148, CST), anti-AR-V7 (19672, CST), anti-AR (ab108341, Abcam), and anti-GAPDH (ab9485, Abcam). After incubation with suitable HRP-conjugated

(6) Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancerOncogeneJuly 1, 2022Dutta S, Polavaram NS, Islam R, Bhattacharya S, Bodas S, Mayr T, Roy S, Albala SAY, Toma MI, Darehshouri A, et al.sc-13117; R&D System AF2215; Protein Atlas, HPA054974), AR (Cell Signaling, 5153), ARv7 (Cell Signaling, 19672), HDAC1 (Cell Signaling, 34589), KLF4 (R&D System, HPA054974; Cell Signaling, 12173), PDI (Cell signaling

(7) A SIX1 degradation inducer blocks excessive proliferation of prostate cancerInternational Journal of Biological SciencesMarch 14, 2022Yuning Liao, Wenshuang Sun, Zhenlong Shao, Yuan Liu, Xiaoyu Zhong, Yuanfei Deng, Fang Liu, Hongbiao Huang, Jinbao Liuanti-cleaved Caspase 3 (#9661), anti-FLAG-tag (#8146), anti-Ki-67 (#9449), anti-AR (#5153), and anti-AR-V7 (#19672) were from Cell Signaling Technology (Beverly, MA); anti-GAPDH (#ab181602) were from Abcam (Cambridge,

(8) Systematic Evaluation for the Influences of the SOX17/Notch Receptor Family Members on Reversing Enzalutamide Resistance in Castration-Resistant Prostate Cancer CellsFrontiers in OncologyMarch 10, 2021Zhongbo Du, Luo Li, Wei Sun, Pingyu Zhu, Shulin Cheng, Xuesong Yang, Chunli Luo, Xiaodong Yu, Xiaohou Wuanti-Zeb-1(1:2,000, Cell Signaling Technology, cat.no.70512s), anti-AR (1:2,000, Cell Signaling Technology, cat.no.19672s), anti-SOX17 (1:2,000, Abcam), anti-Notch1(1:2000, Abcam); anti-Notch2 (1:2,000, CST); anti-Notch3 (1:1,000,

(9) Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinomaAging (Albany NY)February 15, 2021Pengfei Zhu, Ruo Feng, Xu Lu, Yuan Liao, Zhicheng Du, Wenlong Zhai, Kunlun ChenCell Signaling Technology Inc, CST, MA, USA), anti-p-Erk1/2 (4370, Cell Signaling Technology Inc, CST, MA, USA), anti-AR (19672, Cell Signaling Technology Inc, CST, MA, USA), anti-ID1 (ab168256, Abcam, Cambridge, MA, USA), and anti-GAPDH

(10) Androgen Deprivation Induces Transcriptional Reprogramming in Prostate Cancer Cells to Develop Stem Cell-Like CharacteristicsInternational Journal of Molecular SciencesDecember 16, 2020Shiv Verma, Eswar Shankar, F. Naz Cemre Kalayci, Amrita Mukunda, Malek Alassfar, Vaibhav Singh, E. Ricky Chan, Gregory T. MacLennan, Sanjay Guptaall other reagents purchased were of GLP grade. Antibodies including Anti-AR (Cat# 5153), anti-AR-v7 (Cat# 19672), anti-POU5F1 (OCT4) (Cat# 2750S) were purchased from Cell Signaling Technologies, Beverly, MA, USA.

Be the First to Write a Review!

Androgen Receptor (AR-V7 Specific) (E3O8L) Rabbit mAb from Cell Signaling Technology

Description

Cell Signaling Technology

Citations (10)

Reviews

Androgen Receptor (AR-V7 Specific) (E3O8L) Rabbit mAb from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map